ANGEL EBV-specific cytotoxic T-cells

EBV-specific cytotoxic T cells · Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ANGEL EBV-specific cytotoxic T-cells, covering 2017-02-15 to 2017-02-15. Get the full timeline:

Most recent: Clinical Trial Update: Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGEL [Phase 1]